New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome.

@article{Cole2012NewSI,
  title={New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcome.},
  author={Kristina A. Cole and John M. Maris},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2012},
  volume={18 9},
  pages={2423-8}
}
Neuroblastoma remains responsible for a disproportionate amount of childhood cancer morbidity and mortality despite recent significant advances in understanding the genetic basis of tumor initiation and progression. About half of newly diagnosed patients can be reliably identified as having tumors of low malignant potential, and these children have cure… CONTINUE READING